These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20836985)

  • 1. Targeting of the highly conserved threonine 302 residue of cytochromes P450 2B family during mechanism-based inactivation by aryl acetylenes.
    Zhang H; Lin HL; Kenaan C; Hollenberg PF
    Arch Biochem Biophys; 2011 Mar; 507(1):135-43. PubMed ID: 20836985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. tert-Butylphenylacetylene is a potent mechanism-based inactivator of cytochrome P450 2B4: inhibition of cytochrome P450 catalysis by steric hindrance.
    Zhang H; Lin HL; Walker VJ; Hamdane D; Hollenberg PF
    Mol Pharmacol; 2009 Nov; 76(5):1011-8. PubMed ID: 19720728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thr302 is the site for the covalent modification of human cytochrome P450 2B6 leading to mechanism-based inactivation by tert-butylphenylacetylene.
    Lin HL; Zhang H; Pratt-Hyatt MJ; Hollenberg PF
    Drug Metab Dispos; 2011 Dec; 39(12):2431-9. PubMed ID: 21930824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of mammalian cytochrome P450 2B4 covalently bound to the mechanism-based inactivator tert-butylphenylacetylene: insight into partial enzymatic activity.
    Gay SC; Zhang H; Wilderman PR; Roberts AG; Liu T; Li S; Lin HL; Zhang Q; Woods VL; Stout CD; Hollenberg PF; Halpert JR
    Biochemistry; 2011 Jun; 50(22):4903-11. PubMed ID: 21510666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent modification of Thr302 in cytochrome P450 2B1 by the mechanism-based inactivator 4-tert-butylphenylacetylene.
    Lin HL; Zhang H; Jushchyshyn M; Hollenberg PF
    J Pharmacol Exp Ther; 2010 Jun; 333(3):663-9. PubMed ID: 20200115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pivotal role of water in terminating enzymatic function: a density functional theory study of the mechanism-based inactivation of cytochromes P450.
    Hirao H; Cheong ZH; Wang X
    J Phys Chem B; 2012 Jul; 116(27):7787-94. PubMed ID: 22620991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 17-alpha-ethynylestradiol on activities of cytochrome P450 2B (P450 2B) enzymes: characterization of inactivation of P450s 2B1 and 2B6 and identification of metabolites.
    Kent UM; Mills DE; Rajnarayanan RV; Alworth WL; Hollenberg PF
    J Pharmacol Exp Ther; 2002 Feb; 300(2):549-58. PubMed ID: 11805216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P450 active site architecture and reversibility: inactivation of cytochromes P450 2B4 and 2B4 T302A by tert-butyl acetylenes.
    Blobaum AL; Harris DL; Hollenberg PF
    Biochemistry; 2005 Mar; 44(10):3831-44. PubMed ID: 15751959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the structural consequences of mechanism-based inactivation of mammalian cytochrome P450 2B4 using resonance Raman spectroscopy.
    Mak PJ; Zhang H; Hollenberg PF; Kincaid JR
    J Am Chem Soc; 2010 Feb; 132(5):1494-5. PubMed ID: 20078059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism-based inactivation and reversibility: is there a new trend in the inactivation of cytochrome p450 enzymes?
    Blobaum AL
    Drug Metab Dispos; 2006 Jan; 34(1):1-7. PubMed ID: 16369051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
    Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of serine 360 by a reactive intermediate of 17-alpha-ethynylestradiol results in mechanism-based inactivation of cytochrome P450s 2B1 and 2B6.
    Kent UM; Sridar C; Spahlinger G; Hollenberg PF
    Chem Res Toxicol; 2008 Oct; 21(10):1956-63. PubMed ID: 18729327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid residues critical for differential inhibition of CYP2B4, CYP2B5, and CYP2B1 by phenylimidazoles.
    Spatzenegger M; Wang Q; He YQ; Wester MR; Johnson EF; Halpert JR
    Mol Pharmacol; 2001 Mar; 59(3):475-84. PubMed ID: 11179442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent mechanism-based inactivation of cytochrome P450 2B4 by 9-ethynylphenanthrene: implications for allosteric modulation of cytochrome P450 catalysis.
    Zhang H; Gay SC; Shah M; Foroozesh M; Liu J; Osawa Y; Zhang Q; Stout CD; Halpert JR; Hollenberg PF
    Biochemistry; 2013 Jan; 52(2):355-64. PubMed ID: 23276288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
    Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
    Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Phenoxyaniline Analogues To Generate Biochemical Insights into the Interactio n of Polybrominated Diphenyl Ether with CYP2B Enzymes.
    Chen C; Liu J; Halpert JR; Wilderman PR
    Biochemistry; 2018 Feb; 57(5):817-826. PubMed ID: 29215266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5.
    Lin HL; Kent UM; Hollenberg PF
    J Pharmacol Exp Ther; 2005 Apr; 313(1):154-64. PubMed ID: 15608076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxo-iron and oxenoid-iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: switching by threonine-302 to alanine mutagenesis of cytochrome P450 2B4.
    Vaz AD; Pernecky SJ; Raner GM; Coon MJ
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4644-8. PubMed ID: 8643457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism-based inactivation of cytochrome P450 2B6 by a novel terminal acetylene inhibitor.
    Fan PW; Gu C; Marsh SA; Stevens JC
    Drug Metab Dispos; 2003 Jan; 31(1):28-36. PubMed ID: 12485950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of in vitro metabolism of ticlopidine by human cytochrome P450 2B6 and rabbit cytochrome P450 2B4.
    Talakad JC; Shah MB; Walker GS; Xiang C; Halpert JR; Dalvie D
    Drug Metab Dispos; 2011 Mar; 39(3):539-50. PubMed ID: 21156812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.